Cloned Enzyme Donor Immunoassay Tacrolimus Assay Compared With High-Performance Liquid Chromatography-Tandem Mass Spectrometry and Microparticle Enzyme Immunoassay in Liver and Renal Transplant Recipients

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Therapeutic Drug Monitoring

• Publication date

  2007-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/FTD.0b013e31811f25dfPMID 17898648
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Is Microparticle Enzyme-Linked Immunoassay (MEIA) Reliable for Use in Tacrolimus TDM? Comparison of MEIA to Liquid Chromatography With Mass Spectrometric Detection Using Longitudinal Trough Samples From Transplant Recipients

  2006cited by this paper
• Effects of Hematocrit Value on Microparticle Enzyme Immunoassay of Tacrolimus Concentration in Therapeutic Drug Monitoring

  2005cited by this paper
• Hematocrit Influences Immunoassay Performance for the Measurement of Tacrolimus in Whole Blood

  2005cited by this paper
• Tacrolimus Pharmacogenetics: The CYP3A5*1 Allele Predicts Low Dose-Normalized Tacrolimus Blood Concentrations in Whites and South Asians

  2005cited by this paper
• Cytochrome P450 3A4 and P‐glycoprotein Activity and Assimilation of Tacrolimus in Transplant Patients with Persistent Diarrhea

  2005cited by this paper
• Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.

  2005cited by this paper
• Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus.

  2005cited by this paper
• Low hematocrit and serum albumin concentrations underlie the overestimation of tacrolimus concentrations by microparticle enzyme immunoassay versus liquid chromatography-tandem mass spectrometry.

  2005cited by this paper
• The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients.

  2004cited by this paper
• IMx tacrolimus II assay: is it reliable at low blood concentrations? A comparison with tandem MS/MS.

  2002cited by this paper
• Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

  2001cited by this paper
• Comparative Clinical Pharmacokinetics of Tacrolimus in Paediatric and Adult Patients

  2001cited by this paper
• The genetic determinants of the CYP3A5 polymorphism.

  2001cited by this paper
• Analytical performance of microparticle enzyme immunoassay and HPLC-tandem mass spectrometry in the determination of sirolimus in whole blood.

  1999cited by this paper
• Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients.

  1998cited by this paper
• Improved therapeutic drug monitoring of tacrolimus (FK506) by tandem mass spectrometry.

  1997cited by this paper
• Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography-electrospray tandem mass spectrometry.

  1996cited by this paper
• Analysis of Method Comparison Studies

  1996cited by this paper
• Mode of Action of Tacrolimus (FK506): Molecular and Cellular Mechanisms

  1995cited by this paper
• FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects.

  1993cited by this paper
• Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic Studies

  1992cited by this paper
• Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis.

  1987cited by this paper
• Statistical methods for assessing agreement between two methods of clinical measurement.

  1986cited by this paper
• AKUFO AND IBARAPA.

  1965cited by this paper
• Analytical Performance of Microparticle Enzyme Immunoassay and HPLC-Tandem Mass Spectrometry in the Determination of Sirolimus in Whole Blood

  year unknowncited by this paper

• Therapeutic drug monitoring in childhood idiopathic nephrotic syndrome: a state of the art review

  2023cites this paper
• Immunosuppression Monitoring-What Clinician Needs to Know?

  2023cites this paper
• Immunosuppressants

  2022cites this paper
• Overview of therapeutic drug monitoring of immunosuppressive drugs: Analytical and clinical practices.

  2021cites this paper
• Therapeutic drug monitoring of immunosuppressants

  2020cites this paper
• 1 An Experimental Approach To Risk Of Organ 2 Rejection : Demonstration Of False 3 Immunosuppressant Results Due To Radiopaque 4 Agents 5 6

  2019cites this paper
• Issues of Interferences in Therapeutic Drug Monitoring

  2019cites this paper
• False Immunosuppressant Measurement by LC-MS/MS Method Due to Radiopaque Agents.

  2019cites this paper
• Optimization of chromatography to overcome matrix effect for reliable estimation of four small molecular drugs from biological fluids using LC-MS/MS.

  2019cites this paper
• Immunologic Monitoring to Personalize Immunosuppression After Liver Transplant.

  2018cites this paper
• Performance of the Dimension TAC assay and comparison of multiple platforms for the measurement of tacrolimus

  2018cites this paper
• Current methods of the analysis of immunosuppressive agents in clinical materials: A review.

  2016cites this paper
• Limitations of immunoassays used for therapeutic drug monitoring of immunosuppressants

  2016cites this paper
• Immunoassays and Issues With Interference in Therapeutic Drug Monitoring

  2016cites this paper
• Analytical Performance Evaluation of a New Cobas Tacrolimus Assay on Cobas e411 Analyzer: Comparison of Values Obtained by the CMIA Tacrolimus Assay and a Liquid Chromatography Combined with Tandem Mass Spectrometric Method.

  2016cites this paper
• Experiences from using LC-MS/MS for analysis of immunosuppressive drugs in a TDM service.

  2016cites this paper
• [Some thoughts on the links between LC-MS/MS and therapeutic drug monitoring].

  2015cites this paper
• Clinical evaluation of the QMS® Tacrolimus immunoassay.

  2014cites this paper
• Rapid and Sensitive Ultra Performance Liquid Chromatography Tandem Mass Spectrometry for Quantitation of Tacrolimus in Human Whole Blood

  2014cites this paper
• Rapid and sensitive UPLC-MS-MS determination of tacrolimus in Wistar rats and human blood.

  2014cites this paper
• Therapeutic Drug Monitoring of Immunosuppressants: Limitations of Immunoassays and the Need for Chromatographic Methods

  2012cites this paper
• Immunosuppressive Drug Monitoring: Limitations of Immunoassays and the Application of Liquid Chromatography Mass Spectrometry

  2012cites this paper
• Impact of Interferences Including Metabolite Crossreactivity on Therapeutic Drug Monitoring Results

  2012cites this paper
• Therapeutic drug monitoring of tacrolimus by liquid chromatography-tandem mass spectrometry: is it truly a routine test?

  2012cites this paper
• Influence des immunosuppresseurs co-administrés au mycophénolate mofétil lors du dosage de l’acide mycophénolique par technique immuno-enzymatique

  2011cites this paper
• Comparison of the affinity column-mediated immunoassay and microparticle enzyme immunoassay methods as a tacrolimus concentration assay in the early period after liver transplantation.

  2010cites this paper
• Multi-center evaluation of a commercial Kit for tacrolimus determination by LC/MS/MS.

  2010cites this paper
• New Insights Into the Pharmacokinetics and Pharmacodynamics of the Calcineurin Inhibitors and Mycophenolic Acid: Possible Consequences for Therapeutic Drug Monitoring in Solid Organ Transplantation

  2009cites this paper
• Study of the effect of Wuzhi tablet (Schisandra sphenanthera extract) on tacrolimus tissue distribution in rat by liquid chromatography tandem mass spectrometry method.

  2009cites this paper
• Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference

  2009cites this paper
• [Performance evaluation of affinity column mediated immunometric assay for tacrolimus].

  2009influential citation
• Recent development in application of high performance liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressants.

  2008cites this paper
• Comparison of the CEDIA and MEIA assays for measurement of tacrolimus in organ transplant recipients.

  2008cites this paper
• A High-Performance Liquid Chromatography-Mass Spectrometry Method Using a Novel Atmospheric Pressure Chemical Ionization Approach for the Rapid Simultaneous Measurement of Tacrolimus and Cyclosporin in Whole Blood

  2008cites this paper